ArticleInternational journal of chronic obstructive pulmonary disease2025
Imaging Phenotypes Assessment by Using Quantitative Parameters for CT-Defined Subtypes of Chronic Obstructive Pulmonary Disease.
Article in International journal of chronic obstructive pulmonary disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To explore the quantitative imaging phenotype differences for CT-defined subtypes classified by the Fleischner Society in patients with chronic obstructive pulmonary disease (COPD). Patients and Methods: A total of 228 COPD patients who underwent non-enhanced chest CT screening from 2018 to 2024 were included. All patients were divided into type-A (Absent emphysema that no or mild emphysema, Goddard score ≤8, regardless of bronchial wall thickening), type-E (Emphysema that significant emphysema, Goddard score >8, without bronchial wall thickening), and type-M (Mixed emphysema and bronchial wall thickening that both significant emphysema, Goddard score >8, and bronchial wall thickening ≥ grade 1 in ≥1 lung lobe). Imaging phenotype parameters included lung airspace analysis (LAA) and LAA size analysis (LAASA) in emphysema, airway wall, lung vessels and interstitial lung disease (ILD) extracted by a COPD-specific analysis software were analysis among three groups. Results: Quantitative assessment of emphysema among three image phenotypes showed significant differences in full emphysema and full emphysema ratio based on LAA among three groups (P < 0.05). The areas of consolidation, ground-glass opacity, and reticular patterns were significantly larger in type-M than the other two types (P < 0.05). Quantitative assessment of small airways disease and small vessel parameters found smaller lumen-volume and larger wall-volume in whole lung level in the emphysema phenotype of type-M (P < 0.05) were found in the small vessel count in distance of 6 mm and 9mm from the pleura were significant differences among three groups (P < 0.05). The multivariate logistic regression analysis showed that the higher proportion of full emphysema ratio and wall-volume, a proportion of smaller lumen-volume, and a more noticeable interstitial lung alterations were associated with type-M. Conclusion: A quantitative CT evaluation can further delineate the imaging phenotypes characteristics thereby in guiding to early diagnosis, severity assessment, and therapeutic recommendations in COPD patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.